RENBIO, INC.

Profile

Company Names

RENBIO, INC.

Addresses

30-02 48TH AVENUE, LONG ISLAND CITY, NY 11101

430 EAST 29TH STREET, SUITE 600, NEW YORK, NY 10016

Phone Numbers

(646) 440-9411

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$19,250,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-08-22 
$5,250,000.00 
$6,000,000.00 
$750,000.00 
Debt 
1
2020-12-30 
$14,000,000.00 
$24,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHI-CHUAN 
 
CHEN 
DIRECTOR
TIGER MEDIA, INC.   |  RENBIO, INC.
DAVID 
 
CHU 
DIRECTOR
SOMA ISOSCELES FUND LP   |  RENBIO, INC.
JAAP 
 
GOUDSMIT, M.D., PH.D. 
DIRECTOR
RENBIO, INC.
ZHI 
 
HONG, PH.D. 
DIRECTOR
RENBIO, INC.
RACHEL 
A. 
LIBERATORE, PH.D. 
DIRECTOR, EXECUTIVE OFFICER
RENBIO, INC.
ANNELYN 
 
O-ROURKE 
EXECUTIVE OFFICER
RENBIO, INC.
NEAL 
 
PADTE 
EXECUTIVE OFFICER, DIRECTOR
RENBIO, INC.
DONALD 
 
TANG 
DIRECTOR
CATALYST IT SERVICES, INC   |  CATALYTE, INC   |  RENBIO, INC.   |  SENTI BIOSCIENCES, INC.   |  SENTI BIOSCIENCES HOLDINGS, INC.   |  SENTI HOLDINGS, INC.   |  SENTI BIOSCIENCES, INC.
WAN FENG 
 
TING 
DIRECTOR
RENBIO, INC.
TAMON 
 
TSENG 
DIRECTOR
RENBIO, INC.
WALTER 
 
WANG, SR. 
DIRECTOR
RENBIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-08-22 
2021-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#